Literature DB >> 19384167

Outcomes of transplantation using kidneys from donors meeting expanded criteria in Australia and New Zealand, 1991 to 2005.

Michael G Collins1, Sean H Chang, Graeme R Russ, Stephen P McDonald.   

Abstract

BACKGROUND: Kidneys from expanded criteria donors (ECD) are reported to have inferior transplant outcomes.
METHODS: Using the Australia and New Zealand Dialysis and Transplant Registry, we reviewed deceased donor kidneys transplanted from 1991 to 2005 in Australia and New Zealand, followed until December 2006. ECD was defined using United Network for Organ Sharing criteria. Graft and patient outcomes, estimated glomerular filtration rates (eGFR), acute rejection, and delayed graft function were analyzed by donor-age and ECD status, with adjustment for important covariates.
RESULTS: There were 3248 recipients of non-ECD kidneys and 781 recipients of ECD kidneys. Compared with donors aged less than 50 years, adjusted hazard ratios for graft failure (GF) at 0 to 1 and 1 to 5 years for ECD kidneys from donors aged 60 years or above were 1.92 (1.48-2.49; P<0.001) and 2.52 (1.97-3.23; P<0.001). The hazard ratios for GF were 1.87 (1.31-2.70; P<0.05) for ECD kidneys from donors aged 50 to 59 years in the first year but were not increased subsequently. Mean eGFR at 1 year decreased with increasing donor age and ECD status (56.4 [53.8-58.9] mL/min for kidneys from donors aged <50, 46.6 [45.0-48.3] and 43.5 [41.1-45.9] for non-ECD and ECD donors aged 50 to 59 years, respectively, and 38.6 [36.9-40.4] for donors > or =60; P<0.001) but subsequent eGFR loss was similar except for donors aged 60 years or above (P=0.021). Acute rejection and delayed graft function were more frequent in ECD kidney recipients, but the associations between GF and donor age/ECD status were independent of these factors.
CONCLUSIONS: For recipients of ECD kidneys, donor age 60 years or above is the most significant determinant of poor outcome; donor age 50 to 59 years represents a category of intermediate risk.

Entities:  

Mesh:

Year:  2009        PMID: 19384167     DOI: 10.1097/TP.0b013e31819ec3a6

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  8 in total

Review 1.  Strategies for an Expanded Use of Kidneys From Elderly Donors.

Authors:  María José Pérez-Sáez; Núria Montero; Dolores Redondo-Pachón; Marta Crespo; Julio Pascual
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

2.  The Canadian experience using the expanded criteria donor classification for allocating deceased donor kidneys for transplantation.

Authors:  Ann Young; Stephanie N Dixon; Greg A Knoll; Amit X Garg; Charmaine E Lok; Ngan N Lam; S Joseph Kim
Journal:  Can J Kidney Health Dis       Date:  2016-03-24

3.  Efficacy and Safety Outcomes of Extended Criteria Donor Kidneys by Subtype: Subgroup Analysis of BENEFIT-EXT at 7 Years After Transplant.

Authors:  S Florman; T Becker; B Bresnahan; A Chevaile-Ramos; D Carvalho; G Grannas; F Muehlbacher; P J O'Connell; H U Meier-Kriesche; C P Larsen
Journal:  Am J Transplant       Date:  2016-07-12       Impact factor: 8.086

4.  Subclinical Changes in Deceased Donor Kidney Proteomes Are Associated With 12-month Allograft Function Posttransplantation-A Preliminary Study.

Authors:  Maria Kaisar; Leon van Dullemen; Philip Charles; Zeeshan M Akhtar; Marie L Thézénas; Honglei Huang; Astrid Klooster; Nicholas A Watkins; Benedikt Kessler; Rutger J Ploeg
Journal:  Transplantation       Date:  2019-02       Impact factor: 4.939

5.  Adult Living-Donor Kidney Transplantation, Donor Age, and Donor-Recipient Age.

Authors:  Takahisa Hiramitsu; Toshihide Tomosugi; Kenta Futamura; Manabu Okada; Yutaka Matsuoka; Norihiko Goto; Toshihiro Ichimori; Shunji Narumi; Asami Takeda; Takaaki Kobayashi; Kazuharu Uchida; Yoshihiko Watarai
Journal:  Kidney Int Rep       Date:  2021-10-14

6.  Long-term outcomes of kidney transplantation from expanded criteria donors with Chinese novel donation policy: donation after citizens' death.

Authors:  Xiao Fang; Yan Wang; Rong Liu; Changyan Zhu; Chenguang Wu; Fuqiang He; Shunliang Yang; Dong Wang
Journal:  BMC Nephrol       Date:  2022-10-03       Impact factor: 2.585

7.  Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study.

Authors:  A Durrbach; J M Pestana; S Florman; M Del Carmen Rial; L Rostaing; D Kuypers; A Matas; T Wekerle; M Polinsky; H U Meier-Kriesche; S Munier; J M Grinyó
Journal:  Am J Transplant       Date:  2016-06-09       Impact factor: 8.086

8.  Outcomes with Tacrolimus-Based Immunosuppression After Kidney Transplantation from Standard- and Extended-Criteria Donors - A Post Hoc Analysis of the Prospective OSAKA Study.

Authors:  Laetitia Albano; Bernard Banas; Frank Lehner; Maciej Glyda; Ondrej Viklicky; Stefan Schleibner; Malcolm Brown; Nassim Kamar
Journal:  Ann Transplant       Date:  2020-05-29       Impact factor: 1.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.